Advertisement
Canadian Journal of Cardiology

Peripheral Artery Disease: A High-Risk Yet Understudied, Underdiagnosed, and Undertreated Condition—A Call to Action

Published:March 25, 2022DOI:https://doi.org/10.1016/j.cjca.2022.03.016
      The similarities in practice between cardiovascular medicine and vascular surgery are impossible to ignore. The disease processes, the patient population, and the approach to treatment have continued to converge since the report of the first coronary angiography.
      • Gruentzig A.R.
      Percutaneous transluminal coronary angioplasty.
      In both specialties, pushing the limits of novel techniques for intervention has meant that our understanding of cardiovascular disease has evolved and our thought processes and approaches have been refined. And now, as the burden of cardiovascular disease increases globally,
      • Roth G.A.
      • Mensah G.A.
      • Johnson C.O.
      • Addolorato G.
      • Ammirati E.
      • Baddour L.M.
      • et al.
      Global burden of cardiovascular diseases and risk factors, 1990-2019.
      it is our responsibility as cardiovascular specialists to recognise the synergies and build a system that puts patients at the centre of the care team. What better time than the announcement of the 2022 Canadian Cardiovascular Society (CCS) peripheral artery disease (PAD) guidelines to highlight this common ground. The PAD guidelines are a monumental document from the CCS members and vascular specialists to guide care of PAD patients in Canada.
      • Abramson B.L.
      • Al-Omran M.
      • Anand S.S.
      • et al.
      Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease.
      It is the aspiration of these guidelines that at every point of contact, PAD patients are offered optimal diagnostics and receive the best medical management, and interventionalists are guided by the latest evidence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gruentzig A.R.
        Percutaneous transluminal coronary angioplasty.
        Seminars in Roentgenology. 1981; 16: 152-153
        • Roth G.A.
        • Mensah G.A.
        • Johnson C.O.
        • Addolorato G.
        • Ammirati E.
        • Baddour L.M.
        • et al.
        Global burden of cardiovascular diseases and risk factors, 1990-2019.
        J Am Coll Cardiol. 2020; 76: 2982-3021
        • Abramson B.L.
        • Al-Omran M.
        • Anand S.S.
        • et al.
        Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease.
        Can J Cardiol. 2022; 38: 560-587
        • Wan D.
        • Li V.
        • Banfield L.
        • et al.
        Diet and nutrition in peripheral artery disease: a systematic review.
        Can J Cardiol. 2022; 38: 672-680
        • Shovel L.
        • Morkane C.
        Prehabilitation for vascular surgery patients: challenges and opportunities.
        Can J Cardiol. 2022; 38: 645-653
        • Hansen M.E.
        • Springer J.
        • Byram K.
        Diagnostic and therapeutic challenges of vasculitis.
        Can J Cardiol. 2022; 38: 623-633
        • Chan N.C.
        • Xu K.
        • de Vries T.A.C.
        • Eikelboom J.W.
        • Hirsh J.
        Inflammation as a mechanism and therapeutic target in peripheral artery disease.
        Can J Cardiol. 2022; 38: 588-600
        • Bhagirath V.C.
        • Nash D.
        • Wan D.
        • Anand S.S.
        Building your peripheral artery disease toolkit: medical management of peripheral artery disease in 2022.
        Can J Cardiol. 2022; 38: 634-644
        • McClure G.R.
        • Kaplovitch E.
        • Chan N.
        • Anand S.S.
        Antithrombotic therapy in peripheral arterial disease: risk stratification and clinical decision making.
        Can J Cardiol. 2022; 38: 654-661
        • Rymer J.
        • Gutierrez J.A.
        Challenges in peripheral artery disease clinical trial implementation and design.
        Can J Cardiol. 2022; 38: 699-702
        • Eagleton M.J.
        Updates in endovascular procedural navigation.
        Can J Cardiol. 2022; 38: 662-671
        • Coutinho T.
        • Richer J.
        • Boodhwani M.
        Who to screen for thoracic aortic aneurysms, and when to refer for surgery.
        Can J Cardiol. 2022; 38: 695-698
        • Morrison A.
        • Aday A.W.
        Sex as a key determinant of peripheral artery disease: epidemiology, differential outcomes, and proposed biological mechanisms.
        Can J Cardiol. 2022; 38: 601-611
        • Nash D.
        • McClure G.
        • Mastracci T.M.
        • Anand S.S.
        Social deprivation and peripheral artery disease.
        Can J Cardiol. 2022; 38: 612-622